Immunohistochemical Expression of Programmed Death Ligand 1 (PD-L1) and Its Correlation with Clinicopathological Parameters in Breast Carcinoma
Monika Pawar & Satish Arakeri · Asian Oncology Research Journal · 2025
Aims: Breast carcinoma (BC) is the leading cause of tumor burden, with an incidence of 11.8%. The programmed cell death protein 1(PD-1)/programmed death ligand 1 (PD-L1) pathway represents an adaptive immune resistance mechanism that tumor cells exert. Recent updates in the treat...
Open access
Research Article
10.9734/aorj/2025/v8i1108